Safety and Efficacy of Triple Therapeutic Targets with Rivaroxaban after Acute Myocardial Infarction Complicated by Left Ventricular Thrombi in a Case of Nonvalvular Atrial Fibrillation

We present the complex case of a high-risk patient with nonvalvular atrial fibrillation, who experienced a non-ST elevation myocardial infarction complicated by left ventricular (LV) thrombi and underwent percutaneous coronary intervention with drug-eluting stent implantation. The patient was initia...

Full description

Saved in:
Bibliographic Details
Main Authors: Francesco Summaria, Gregory A. Sgueglia, Fabrizio D’Errico, Antonella De Santis, Fabiana Piccioni, Gaetano Gioffrè, Achille Gaspardone
Format: Article
Language:English
Published: Wiley 2018-01-01
Series:Case Reports in Cardiology
Online Access:http://dx.doi.org/10.1155/2018/6503435
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850165245840982016
author Francesco Summaria
Gregory A. Sgueglia
Fabrizio D’Errico
Antonella De Santis
Fabiana Piccioni
Gaetano Gioffrè
Achille Gaspardone
author_facet Francesco Summaria
Gregory A. Sgueglia
Fabrizio D’Errico
Antonella De Santis
Fabiana Piccioni
Gaetano Gioffrè
Achille Gaspardone
author_sort Francesco Summaria
collection DOAJ
description We present the complex case of a high-risk patient with nonvalvular atrial fibrillation, who experienced a non-ST elevation myocardial infarction complicated by left ventricular (LV) thrombi and underwent percutaneous coronary intervention with drug-eluting stent implantation. The patient was initially treated with short-term triple therapy including aspirin, clopidogrel, and rivaroxaban 15 mg/die. Following aspirin dropping one month after discharge, the patient continued on dual therapy with clopidogrel and rivaroxaban, and a clinical and imaging follow-up at 6 and 12 months confirmed the LV thrombi resolution, with no thromboembolic episodes and a good safety profile.
format Article
id doaj-art-ec216c72bb394beeb3d8a552021f712d
institution OA Journals
issn 2090-6404
2090-6412
language English
publishDate 2018-01-01
publisher Wiley
record_format Article
series Case Reports in Cardiology
spelling doaj-art-ec216c72bb394beeb3d8a552021f712d2025-08-20T02:21:47ZengWileyCase Reports in Cardiology2090-64042090-64122018-01-01201810.1155/2018/65034356503435Safety and Efficacy of Triple Therapeutic Targets with Rivaroxaban after Acute Myocardial Infarction Complicated by Left Ventricular Thrombi in a Case of Nonvalvular Atrial FibrillationFrancesco Summaria0Gregory A. Sgueglia1Fabrizio D’Errico2Antonella De Santis3Fabiana Piccioni4Gaetano Gioffrè5Achille Gaspardone6Department of Cardiology, San Eugenio Hospital, Rome, ItalyDepartment of Cardiology, San Eugenio Hospital, Rome, ItalyDepartment of Cardiology, San Eugenio Hospital, Rome, ItalyDepartment of Cardiology, San Eugenio Hospital, Rome, ItalyDepartment of Cardiology, San Eugenio Hospital, Rome, ItalyDepartment of Cardiology, San Eugenio Hospital, Rome, ItalyDepartment of Cardiology, San Eugenio Hospital, Rome, ItalyWe present the complex case of a high-risk patient with nonvalvular atrial fibrillation, who experienced a non-ST elevation myocardial infarction complicated by left ventricular (LV) thrombi and underwent percutaneous coronary intervention with drug-eluting stent implantation. The patient was initially treated with short-term triple therapy including aspirin, clopidogrel, and rivaroxaban 15 mg/die. Following aspirin dropping one month after discharge, the patient continued on dual therapy with clopidogrel and rivaroxaban, and a clinical and imaging follow-up at 6 and 12 months confirmed the LV thrombi resolution, with no thromboembolic episodes and a good safety profile.http://dx.doi.org/10.1155/2018/6503435
spellingShingle Francesco Summaria
Gregory A. Sgueglia
Fabrizio D’Errico
Antonella De Santis
Fabiana Piccioni
Gaetano Gioffrè
Achille Gaspardone
Safety and Efficacy of Triple Therapeutic Targets with Rivaroxaban after Acute Myocardial Infarction Complicated by Left Ventricular Thrombi in a Case of Nonvalvular Atrial Fibrillation
Case Reports in Cardiology
title Safety and Efficacy of Triple Therapeutic Targets with Rivaroxaban after Acute Myocardial Infarction Complicated by Left Ventricular Thrombi in a Case of Nonvalvular Atrial Fibrillation
title_full Safety and Efficacy of Triple Therapeutic Targets with Rivaroxaban after Acute Myocardial Infarction Complicated by Left Ventricular Thrombi in a Case of Nonvalvular Atrial Fibrillation
title_fullStr Safety and Efficacy of Triple Therapeutic Targets with Rivaroxaban after Acute Myocardial Infarction Complicated by Left Ventricular Thrombi in a Case of Nonvalvular Atrial Fibrillation
title_full_unstemmed Safety and Efficacy of Triple Therapeutic Targets with Rivaroxaban after Acute Myocardial Infarction Complicated by Left Ventricular Thrombi in a Case of Nonvalvular Atrial Fibrillation
title_short Safety and Efficacy of Triple Therapeutic Targets with Rivaroxaban after Acute Myocardial Infarction Complicated by Left Ventricular Thrombi in a Case of Nonvalvular Atrial Fibrillation
title_sort safety and efficacy of triple therapeutic targets with rivaroxaban after acute myocardial infarction complicated by left ventricular thrombi in a case of nonvalvular atrial fibrillation
url http://dx.doi.org/10.1155/2018/6503435
work_keys_str_mv AT francescosummaria safetyandefficacyoftripletherapeutictargetswithrivaroxabanafteracutemyocardialinfarctioncomplicatedbyleftventricularthrombiinacaseofnonvalvularatrialfibrillation
AT gregoryasgueglia safetyandefficacyoftripletherapeutictargetswithrivaroxabanafteracutemyocardialinfarctioncomplicatedbyleftventricularthrombiinacaseofnonvalvularatrialfibrillation
AT fabrizioderrico safetyandefficacyoftripletherapeutictargetswithrivaroxabanafteracutemyocardialinfarctioncomplicatedbyleftventricularthrombiinacaseofnonvalvularatrialfibrillation
AT antonelladesantis safetyandefficacyoftripletherapeutictargetswithrivaroxabanafteracutemyocardialinfarctioncomplicatedbyleftventricularthrombiinacaseofnonvalvularatrialfibrillation
AT fabianapiccioni safetyandefficacyoftripletherapeutictargetswithrivaroxabanafteracutemyocardialinfarctioncomplicatedbyleftventricularthrombiinacaseofnonvalvularatrialfibrillation
AT gaetanogioffre safetyandefficacyoftripletherapeutictargetswithrivaroxabanafteracutemyocardialinfarctioncomplicatedbyleftventricularthrombiinacaseofnonvalvularatrialfibrillation
AT achillegaspardone safetyandefficacyoftripletherapeutictargetswithrivaroxabanafteracutemyocardialinfarctioncomplicatedbyleftventricularthrombiinacaseofnonvalvularatrialfibrillation